GPC3 targeted CAR-DC cell therapy (Peking University Shenzhen Hospital)

靶向GPC3的CAR-DC（北京大学深圳医院）

Report date: 2026/04/17 20:02:02

Base Information

Drug NameGPC3 targeted CAR-DC cell therapy (Peking University Shenzhen Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Chimeric antigen receptor dendritic cell therapy
Mechanisms of ActionDendritic cells modulatorsAnti-Glypican-3
TargetsGlypican-3
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesPeking University Shenzhen Hospital
China Registration ClassN/A

Develop Information

Active CompaniesPeking University Shenzhen Hospital
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A